Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial
Carlo Scognamiglio Renner Araújo, Ana Cristina de Medeiros Ribeiro, Carla Gonçalves Schahin Saad, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, Andrea Yukie Shimabuco, Matheus Santos Rodrigues Silva, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Tatiana do Nascimento Pedrosa, Léonard de Vinci Kanda Kupa, Gioanna Zou, Rosa Maria Rodrigues Pereira, Clóvis A. Silva, Nádia Emi Aikawa, Eloísa Bonfá
Topics & Concepts
MedicineDiscontinuationMethotrexateRheumatoid arthritisSeroconversionInternal medicineImmunogenicityPrednisoneClinical trialHazard ratioRandomized controlled trialGastroenterologyImmunologyAntibodyConfidence intervalRheumatoid Arthritis Research and TherapiesSARS-CoV-2 and COVID-19 ResearchPeripheral Neuropathies and Disorders